Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expanding Bioshield: a call for caution.

Thomas May1

  • 1Center for the Study of Bioethics, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA. tmay@mcw.edu

American Journal of Public Health
|April 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

BMC medical genomics·2026
Same author

Elective genomic sequencing for adults in research, clinical and commercial contexts.

medRxiv : the preprint server for health sciences·2026
Same author

Hohfeld, Berlin and the Social Dimensions of Rights of Conscience in Health Care.

The American journal of bioethics : AJOB·2026
Same author

CAU-10-H: Synthesis Scale-Up at the Pilot Scale, Techno-Economic Analysis, and Application in a Full-Scale Cooling System.

Industrial & engineering chemistry research·2026
Same author

Ableism in Ambient Intelligence Systems' Source Data Related to Clinical Return-of-Result Conversations.

The American journal of bioethics : AJOB·2026
Same author

Factors influencing trustworthiness and perceived biases of medical information and genetic testing for Black and White Americans.

PLoS genetics·2025
Same journal

Erratum In: "Ogunbajo et al. Respond".

American journal of public health·2026
Same journal

The Role of Gender in HIV Care Engagement Among Individuals Assigned Male Sex at Birth: Medical Monitoring Project, United States, 2015-2022.

American journal of public health·2026
Same journal

Domestic Returns to Predictable US Participation in the World Health Organization: Health Security and Cost.

American journal of public health·2026
Same journal

The Risks of Mortality, Cardiovascular Events, and Pulmonary Complications in Cancer Patients Who Smoke Cigarettes and Switch to E-Cigarettes: South Korea, 2015‒2022.

American journal of public health·2026
Same journal

Retailers CARE Program in Montgomery County, Ohio, Partners With Alcohol, Tobacco, and Lottery Retailers to Promote Healthier Communities.

American journal of public health·2026
Same journal

Trends in Sexual Activity, Condom Use, and Use of Pregnancy Prevention Methods Among Female Adolescents: United States, 2007-2023.

American journal of public health·2026
See all related articles

The Bioshield Initiative aims to develop countermeasures against bioterrorism agents. Expanding patent protections for these drugs may create production and research issues, making the strategy potentially unacceptable due to practical and ethical concerns.

Area of Science:

  • Biosecurity
  • Pharmaceutical Policy
  • Public Health

Background:

  • The Bioshield Initiative focuses on developing medical countermeasures against bioterrorism threats.
  • Recent proposals suggest expanding patent protections for these specific drugs and vaccines.
  • Such expansions aim to incentivize development in a critical public health area.

Purpose of the Study:

  • To evaluate the implications of expanded patent protections for drugs and vaccines against bioterrorism agents.
  • To explore alternative strategies for incentivizing the development of medical countermeasures.
  • To assess the practical and ethical considerations associated with proposed patent law changes.

Main Methods:

  • Policy analysis of intellectual property law in the context of biodefense.

Related Experiment Videos

  • Economic modeling of R&D incentives for pharmaceutical development.
  • Ethical framework analysis of public health interventions and patent law.

    • Main Results:

    • Strengthening patent protections on non-bioterrorism related drugs may be a more viable incentive strategy.
    • Expanded patent protections for biodefense countermeasures could lead to production capacity issues.
    • Expanded patent protections may also hinder subsequent research and development efforts.
    • Practical and ethical concerns suggest that expanded patent protections may be an unacceptable strategy.

    Conclusions:

    • Alternative approaches to patent strengthening should be considered for biodefense countermeasures.
    • The potential negative impacts on production and further R&D must be carefully weighed against the benefits of expanded patent protection.
    • Ethical and practical considerations render the proposed expansion of patent protections for bioterrorism-related drugs and vaccines potentially unacceptable.